MoringaBase
Back to research

Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.

Fatiha RA, Ngabdi CK, Azizah JS, Putri BSN, Lestari B, Malek NANN, Susanto H, Riawan W, Permatasari HK

Asian Pacific journal of cancer prevention : APJCP1 March 2026
20
Early
In VitroPositiveAnticancer

Fatiha RA, Ngabdi CK, Azizah JS et al. (2026). Disruption of EMT Signaling and Migration by Moringa oleifera Leaf Powder-Silver Nanoparticles (MOLP-AgNPs) in HeLa Cervical Cancer Cells.. Asian Pacific journal of cancer prevention : APJCP.

This laboratory study investigated whether silver nanoparticles made from moringa leaf powder could affect cancer cell behavior, specifically focusing on cervical cancer cells. Researchers created special nanoparticles by combining moringa leaf powder with silver (MOLP-AgNPs) and tested them on HeLa cervical cancer cells in laboratory dishes. The scientists were particularly interested in a process called epithelial-mesenchymal transition (EMT), which is when cancer cells change their characteristics to become more mobile and potentially spread to other parts of the body. The researchers tested three different concentrations of the moringa-silver nanoparticles and measured how they affected cell movement and the production of specific proteins associated with cancer cell mobility. They found that the nanoparticles significantly reduced the cancer cells' ability to move and migrate, doing so in a dose-dependent manner - meaning higher concentrations had stronger effects. The treatment also reduced the production of two key proteins, Snail and vimentin, which are involved in making cancer cells more aggressive and mobile. While this is early-stage laboratory research using a specific type of cervical cancer cell line, the findings suggest that combining moringa with silver nanoparticles might interfere with processes that help cancer cells spread, though much more research would be needed before any clinical applications could be considered.

Study details

Population

In vitro study using HeLa cervical cancer cell line

Plant part

Leaf

Preparation

Powder

Dosage

2, 4, and 6 μg/mL concentrations of MOLP-AgNPs

Dosage protocol

2, 4, and 6 µg/mL MOLP-AgNPs applied to HeLa cervical cancer cells in laboratory culture, duration not specified in abstract

Key compounds

silver nanoparticles

Related studies